[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Remote Patient Monitoring Systems: Market Research Report

January 2015 | 273 pages | ID: RFD7E8AA26FEN
Global Industry Analysts, Inc

US$ 4,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report analyzes the worldwide markets for Remote Patient Monitoring Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 83 companies including many key and niche players such as -
  • Abbott Laboratories
  • Aerotel Medical Systems
  • AMD Global Telemedicine, Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Remote Patient Monitoring (RPM) – A Transformation Model for Health Care Delivery
Benefits for Patients, Physicians, & Payer
Improved Patient Outcomes and Promoting Self-Care
Resource Optimization and Savings – A Key Benefit
Payer Benefits
Peek into Key Market Growth Drivers
Focus on Healthcare Economics Grows as Healthcare Expenditures Rise Globally

Table 1. Global Healthcare Spending (in US$ Trillion): 2013-2018 (includes corresponding Graph/Chart)
Table 2. Healthcare Expenditure as a % of GDP Across Select Countries (includes corresponding Graph/Chart)
Table 3. Elderly Healthcare Expenditure as a % of GDP (includes corresponding Graph/Chart)

Aging Population Creates High Demand

Table 4. Ageing (65+) Demographics as % of Total Population by Country (2000, 2011, 2020) (includes corresponding Graph/Chart)

Chronic Disease Management Presents Huge Market Opportunity

Table 5. World Market for Telehealth: Patient Distribution (in %) by Disease Condition (includes corresponding Graph/Chart)
Table 6. Chronic Disease Management in Developed Countries (2014): Percentage Distribution of Patient Population by Chronic Disease Type in the US, Germany, and the UK (includes corresponding Graph/Chart)

Readmission Penalty on Hospitals Provides Impetus to RPM
Patient Non-Adherence to Prescribed Medication Promotes RPM Market

Table 7. Medication Adherence Rates in the US by Condition (2012) (includes corresponding Graph/Chart)

Wearable Devices Help Boost RPM Adoption
Venture Capitalists Keen to Fund RPM Technology Companies

Table 8. Digital Health Venture Funding in the US (2011-2014) (includes corresponding Graph/Chart)
Table 9. US Digital Health Venture Capital Funding by Category (in %): 2014 (includes corresponding Graph/Chart)

Market Issues and Challenges
High Cost of Remote Patient Monitoring Systems
Lack of Reimbursement
Patient Privacy Concerns
Small Practices Challenged by Remote Monitoring Programs
Security Issues of Medical Devices
Competitor Landscape

Table 10. Leading Players in the Global Remote Patient Monitoring Market: Percentage Breakdown of Market Share for Boston Scientific, GE Healthcare, Medtronic, Philips Healthcare, St. Jude Medical, and Others (includes corresponding Graph/Chart)

2. MARKET TRENDS/ISSUES

Big Data Management Crucial for Effective RPM
Internet of Things (IoT) – Crucial for Healthcare
Cloud Computing: Enhancing RPM Adoption
Partnerships Leverage on Mutual Expertise
Will mHealth make Conventional RPM Obsolete?
Wireless Consumer Devices Favored Over Telehealth
Immobile Patients to Gain from Increased Uptake of Remote Monitoring Devices
CVD Continues to Grab Focus for Remote Monitoring

Table 11. Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
Table 12. Economic Burden of Cardiovascular Diseases between 2011 and 2015: Breakdown of Lost Output Value by Income Group (includes corresponding Graph/Chart)

Remote Monitoring – New Standard of Care for Patients with CIEDs
RPM to Reduce Costs Associated with Diabetes Management

Table 13. Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)
Table 14. Top Ten Countries Worldwide with the Highest Number of People (in the Age Group 20-79 Years) with DM (in Millions): 2014E & 2035P (includes corresponding Graph/Chart)

Remote Monitoring for Neurodegenerative Disease Conditions
Remote Monitoring of EEG & Treatment Adequacy
Remote Monitoring Crucial for COPD and Asthma Management
Rising Significance of Remote Blood Pressure Monitoring Benefits Market Adoption

Table 15. Death Rates Due to Hypertension in Select Countries: 2012 (includes corresponding Graph/Chart)
Table 16. Percentage Prevalence Rate of High Blood Pressure for Patients over 25 Years of Age by Region (1980 and 2013) - Africa, America, South East Asia, Europe, Eastern Mediterranean, and Western Pacific (includes corresponding Graph/Chart)

Remote Patient Monitoring for Sleep Apnea

Table 17. Percentage Prevalence of Sleep Apnea in Co-Morbidities by Type of Co-Morbidity (includes corresponding Graph/Chart)

3. PRODUCT OVERVIEW

Introduction
Remote Patient Monitoring vs. Telehealth
Current Monitoring Systems - A Systematic Review
Remote Patient Monitoring - Architecture
Benefits & Challenges of Remote Patient Monitoring Systems

4. PRODUCT LAUNCHES/APPROVALS

Omron Healthcare Launches BP Monitor
ALR Technologies Seeks FDA Approval for New Health-e-Connect Feature
HTC Launches Monitoring Device HTC Grip
Covidien Receives CE Marking for Nellcor System
Intel-GE Launches Branded Health Harmony RPM Service
Dexcom Receives FDA Approval for Dexcom SHARE Device
Honeywell Unveils New Version of Genesis DM
Honeywell Unveils Latest Version of LifeStream
AMD Introduces Live Streaming Ultrasound Technology
Vital Connect Receives FDA Clearance for HealthPatch Biosensor
OSTAR Healthcare Launches Remote Patient Monitoring System in North America
Masimo’s Radius-7 Wearable Monitor Receives CE Approval
CardioMEMS System Receives FDA Approval
ReliantHeart’s Assist5 Ventricular Assist Device Receives CE Certification
HealthInterlink Receives 510(k) clearance for Beacon version 2.
Verizon Receives FDA Clearance for Patient Engagement Tool
Sensiotec Unveils Version 2. 0 of Virtual Medical Assistant
InfoBionic Receives CE Certification for MoMe System
Baxter Receives CE Marking for VIVIA Hemodialysis System
Verizon Launches Remote Patient Monitoring Platform
Preventice Receives CE Certification for BodyGuardian Monitoring System
Sorin’s Smartview System Receives FDA Approval
Healthx Launches Remote Patient Monitoring Platform
Tactio Health Group Launches TactioDiabetes
FDA Approves RP-VITA By iRobot Corp. & InTouch Health

5. RECENT INDUSTRY ACTIVITY

Integrity Applications Enters Distribution Agreements with Chinese Players
Roche and Qualcomm Enter Collaboration
Honeywell Life Care and MobileHelp Expand Collaboration
Honeywell HomMed Changes Name to Honeywell Life Care
Welch Allyn Acquires HealthInterLink
LabCorp and Envision Healthcare Invest in Vivify Health
Vital Connect Enters Partnership with LifeWatch
Aerocrine Collaborates with Microsoft
Preventice and eCardio Diagnostics Enter Strategic Partnership
Geneia Acquires Select Rights on ZephyrLIFE From Covidien
Healthsense Raises Funding for Remote Patient Monitoring System
Maxis Bhd and EWL Announce Partnership for Health Monitoring M2M Solution
eCardio Signs Agreement with Shandong Yocaly
Medtronic Acquires Cardiocom
CardioNet Enters Agreement with IMEC & Holst Centre

6. FOCUS ON SELECT GLOBAL PLAYERS

Abbott Laboratories (US)
Aerotel Medical Systems (Israel)
AMD Global Telemedicine, Inc. (US)
BIOTRONIK SE & Co. KG (Germany)
Boston Scientific Corporation (US)
GE Healthcare Ltd. (UK)
Honeywell Life Care Solutions (US)
Intelesens Ltd. (UK)
LifeWatch AG (Switzerland)
Masimo Corporation (US)
Medtronic Plc (Ireland)
Mindray North America (US)
Nihon Kohden Corporation (Japan)
Omron Healthcare, Inc. (US)
Philips Healthcare (Netherlands)
Qualcomm Life, Inc. (US)
St. Jude Medical Inc. (US)
Welch Allyn, Inc. (US)

7. GLOBAL MARKET PERSPECTIVE

Table 18. World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 19. World Historic Review for Remote Patient Monitoring Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 20. World 14-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Key Drivers to Remote Patient Monitoring Market
Remote Monitoring Boosted by HRRP
High Life Expectancy Presents Strong Need for RPM

Table 21. Population of the US (2010, 2030 & 2050): Percentage Breakdown by Age Groups - Under 18, 18-64 years & 65+ years (includes corresponding Graph/Chart)

US – The Leading Market for Remote Cardiac Monitoring

Table 22. CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart)
Table 23. CVD in the US: Cardiovascular Disease Incidence by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart)
Table 24. Leading Causes of CVD Fatalities in the US: Percentage Breakdown of Mortality for Coronary Heart Disease, HBP, Heart Failure, Stroke, and Others (includes corresponding Graph/Chart)

Chronic Disease Management – Focus Area for Remote Monitoring

Table 25. US Healthcare Spending (2006-2020) (in US$ Trillion) (includes corresponding Graph/Chart)
Table 26. US Healthcare Market: Total Annual Expenditure in US$ Billion by Chronic Disorder/Disease (includes corresponding Graph/Chart)

Diabetes Statistics in the US

Table 27. Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group

Sleep Apnea in the US
Rise in COPD Incidence Drives RPM Adoption

Table 28. Chronic Obstructive Pulmonary Disorder (COPD) Incidence in US (2014): COPD Prevalence in Millions by Age Group (includes corresponding Graph/Chart)

Reimbursement Scenario
Remote Monitoring Systems with FDA 510(k) Clearance (2014):
Product Launches
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 29. US Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 30. US Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Product Launch
B. Market Analytics

Table 31. Canadian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 32. Canadian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Graying Population Spurs Growth of Patient Monitoring Equipment

Table 33. Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)

Key Player - Nihon Kohden Corporation
B. Market Analytics

Table 34. Japanese Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 35. Japanese Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Prevalence of Diabetes in Europe: Market Opportunity for CGM Devices
B. Market Analytics

Table 36. European Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 37. European Historic Review for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 38. European 14-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4A. FRANCE

Market Analysis

Table 39. French Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 40. French Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Key Player - Biotronik SE & Co. KG
B. Market Analytics

Table 41. German Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 42. German Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Product Launch
B. Market Analytics

Table 43. Italian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 44. Italian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Telecare and Elderly Population Requirements – An Overview
Self-Monitoring Blood Glucose Meters Gain Popularity
Product Approval
Key Players
B. Market Analytics

Table 45. UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 46. UK Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4E. SPAIN

Market Analysis

Table 47. Spanish Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 48. Spanish Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4F. RUSSIA

Market Analysis

Table 49. Russian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 50. Russian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Strategic Corporate Developments
Key Players
B. Market Analytics

Table 51. Rest of European Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 52. Rest of European Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Outlook
Improving Infrastructure Facilitates RPM Adoption
Undiagnosed Diabetic Population Offers Potential for Remote Monitoring
B. Market Analytics

Table 53. Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 54. Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 55. Asia-Pacific 14-Year Perspective for Remote Patient Monitoring Systems by Region - Percentage Breakdown of Value Sales for China and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis
Large Population Results in Quicker RPM Adoption

Table 56. Healthcare Expenditure in China as a % of GDP (2006-2015) (includes corresponding Graph/Chart)
Table 57. Percentage of Population Aged 65 and Above in China (2000-2020) (includes corresponding Graph/Chart)
Table 58. Incidence of Chronic Diseases in China (2014) (includes corresponding Graph/Chart)

China: An Untapped Goldmine for Blood Glucose Monitoring Devices
Strategic Corporate Development
B. Market Analytics

Table 59. Chinese Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 60. Chinese Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5B. REST OF ASIA-PACIFIC

A. Market Analysis
India: Remote Patient Monitoring Gains Popularity
Rising Diabetic Populace Spurs Growth in Remote Glucose Monitoring Devices
Strategic Corporate Development
B. Market Analytics

Table 61. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 62. Rest of Asia-Pacific Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. LATIN AMERICA

Market Analysis

Table 63. Latin American Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 64. Latin American Historic Review for Remote Patient Monitoring Systems by Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 65. Latin American 14-Year Perspective for Remote Patient Monitoring Systems by Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6A. BRAZIL

Market Analysis

Table 66. Brazilian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 67. Brazilian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6B. REST OF LATIN AMERICA

Market Analysis

Table 68. Rest of Latin American Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 69. Rest of Latin American Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Key Player - Aerotel Medical Systems (Israel)
B. Market Analytics

Table 70. Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 71. Rest of World Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 83 (including Divisions/Subsidiaries - 85)
The United States (55)
Canada (6)
Japan (1)
Europe (16)
  Germany (3)
  The United Kingdom (4)
  Italy (1)
  Rest of Europe (8)
Asia-Pacific (Excluding Japan) (4)
Middle East (3)


More Publications